Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2014
12/09/2014US8907095 Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
12/09/2014US8907094 Kinase inhibitors
12/09/2014US8907090 Processes for preparing different forms of (S)-(+)-Clopidogrel bisulfate
12/09/2014US8907089 Fused heterocyclic ring derivative and use thereof
12/09/2014US8906936 Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereof
12/09/2014US8906935 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them
12/09/2014US8906929 Inhibitors of human immunodeficiency virus replication
12/09/2014US8906928 Substituted pyrazolo-pyrrolo-pyridine-dione compounds
12/09/2014US8906925 Pyrido[4,3-B]indoles containing rigid moieties
12/09/2014US8906923 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
12/09/2014US8906922 Substituted triazoles useful as AXl inhibitors
12/09/2014US8906913 Azabicyclohexanes
12/09/2014US8906912 Anxiolytic compounds
12/09/2014US8906910 Imidazopyridine derivatives as PI3 kinase
12/09/2014US8906900 PRMT5 inhibitors and uses thereof
12/09/2014US8906521 Organic electroluminescent device having triptycene derivative material
12/04/2014US20140357663 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl- 2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
12/04/2014US20140357654 METHODS OF TREATING SCHIZOPHRENIA WITH PHENYLALANINE ENAMIDE DERIVATIVE INHIBITORS OF a4 INTEGRIN POSSESSING A CYCLOBUTENE GROUP
12/04/2014US20140357653 Chemical compounds
12/04/2014US20140357650 Novel fap inhibitors
12/04/2014US20140357642 IP receptor agonist heterocyclic compounds
12/04/2014US20140357641 IP receptor agonist heterocyclic compounds
12/04/2014US20140357639 Imidazole derivatives as PDE10 enzyme inhibitors
12/04/2014US20140357637 Substituted annulated pyrimidines and triazines, and use thereof
12/04/2014US20140357633 Compounds for inhibiting the interaction of bcl2 with binding partners
12/04/2014US20140357625 Diazepinone derivatives
12/04/2014US20140357623 New enzyme inhibitor compounds
12/04/2014US20140357621 Organic Compounds
12/04/2014US20140357618 Substituted imidazopyridines as hdm2 inhibitors
12/04/2014US20140357617 Novel heterocyclic acrylamides and their use as pharmaceuticals
12/04/2014US20140357616 Pyrrolopyridine inhibitors of kinases
12/04/2014US20140357612 Compounds for kinase modulation, and indications therefor
12/04/2014US20140356873 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings
12/04/2014US20140356322 Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
12/04/2014US20140352715 Cationic tetrahydropyrazolopyridines, dye composition comprising such oxidation bases, implementation process therefor and use thereof
12/02/2014US8901540 Fused ring compounds useful in organic thin-film transistors
12/02/2014US8901345 Process for preparation of optically active diamine derivative salt
12/02/2014US8901309 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
12/02/2014US8901305 Aryl lactam kinase inhibitors
12/02/2014US8901301 Pyrrolo[2,3-]pyridine kinase inhibitors
12/02/2014US8901293 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
12/02/2014US8901175 Use of opioids or opioid mimetics for the treatment of resistant cancer patients
12/02/2014US8901149 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
12/02/2014US8901144 Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
12/02/2014US8901136 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
12/02/2014US8901133 Heterocyclic compounds and uses thereof
12/02/2014US8901125 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors
12/02/2014US8901124 Pyridazine amide compounds useful as SYK inhibitors
12/02/2014US8901119 Peptide deformylase inhibitors
12/02/2014US8901118 Compounds and methods for kinase modulation, and indications therefor
12/02/2014US8901115 Cyclic P1 linkers as factor XIa inhibitors
12/02/2014US8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/02/2014US8901108 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists
11/2014
11/27/2014US20140350260 Heterocyclic compound and use thereof
11/27/2014US20140350259 Process for the preparation of 2-phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives
11/27/2014US20140350257 Process for the Preparation of a DPP-IV Inhibitor
11/27/2014US20140350248 Chemical entities and therapeutic uses thereof
11/27/2014US20140350244 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
11/27/2014US20140350046 Pyrazolopyridinone derivatives as lpa receptor antagonists
11/27/2014US20140350043 Fsh receptor antagonists
11/27/2014US20140350031 Piperidino-pyrimidine derivatives for the treatment of viral infections
11/27/2014US20140350024 Antimicrobial agents
11/27/2014US20140350020 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
11/27/2014US20140350015 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
11/27/2014US20140350011 Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders
11/27/2014US20140350007 Crystalline forms of tricyclic compound acid salt or hydrate thereof, and method for making thereof
11/27/2014US20140350006 Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof
11/27/2014US20140350005 D2 antagonists, methods of synthesis and methods of use
11/27/2014US20140350002 Imidazopyridin-2-one derivatives
11/27/2014US20140349998 Pyrrolopyrimidines as janus kinase inhiitors
11/27/2014US20140349995 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators
11/27/2014US20140349992 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/27/2014US20140349990 Pyrazolopyrrolidine Derivatives and their Use in the Treatment of Disease
11/27/2014US20140349989 Compounds and therapeutic uses thereof
11/27/2014US20140349987 PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORy, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
11/27/2014US20140349970 Novel tricyclic compounds
11/27/2014US20140349967 Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
11/25/2014US8895745 Bicyclic heterocyclic compounds as FGFR inhibitors
11/25/2014US8895744 Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl
11/25/2014US8895743 Methysergide derivatives
11/25/2014US8895738 Mesoionic pyrido [1, 2-A] pyrimidine pesticides
11/25/2014US8895726 Compounds derived from indole and pharmaceutical compositions containing them
11/25/2014US8895599 Lipoprotein lipase-activating compositions comprising benzene derivates
11/25/2014US8895582 Certain chemical entities, compositions, and methods
11/25/2014US8895581 1H-imidazo[4,5-c]quinolines
11/25/2014US8895580 Quinolinone-pyrazolone M1 receptor positive allosteric modulators
11/25/2014US8895578 Carboxamide, sulfonamide and amine compounds and methods for using the same
11/25/2014US8895577 Compounds and compositions as TLR activity modulators
11/25/2014US8895575 1 H-pyrrolo[2,3-b]pyridine derivatives
11/25/2014US8895572 Fused heterocyclic indane carboxamide CGRP receptor antagonists
11/25/2014US8895571 Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors
11/25/2014US8895560 Opioid antagonists
11/25/2014US8895554 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
11/25/2014US8895550 Triazolopyridine compounds as PIM kinase inhibitors
11/25/2014US8895549 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/25/2014US8895548 Pharmaceutical composition for treating alzheimer's disease
11/25/2014US8895545 Acrylamide derivatives as Fab I inhibitors
11/25/2014US8895544 Indazoles
11/25/2014US8895313 Ligands for aggregated tau molecules
11/25/2014US8895207 Materials and their use for the electrocatalytic evolution or uptake of H2
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 646